Tag: Preclinical imaging market segments

  • Preclinical Imaging Market Key Insights 2024-2033: Growth Rate, Trends And Opportunities

    Preclinical Imaging Market Key Insights 2024-2033: Growth Rate, Trends And Opportunities

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Projected Growth Rate of the Preclinical Imaging Market from 2024 to 2033?

    The size of the preclinical imaging market has seen substantial growth over the recent years. An increase from $3.2 billion in 2023 to $3.44 billion in 2024 is predicted, with a compound annual growth rate (CAGR) of 7.4%. The expansion seen in the past can be credited to governmental initiatives, increase in illnesses, evolving applications, heightened consciousness, and the growth of emerging markets.

    In the upcoming years, the preclinical imaging market is projected to experience robust growth. It is estimated to reach $4.42 billion in 2028, with a compound annual growth rate (CAGR) of 6.5%. Factors contributing to its growth during the forecast period include the adoption of personalized medicine, progress in molecular imaging, outsourcing of drug development, regulatory support, and escalating chronic diseases. The major trends forecasted for this period involve green imaging technologies, advancements in technology, increase in research and development activities, collaborations, partnerships, and real-time imaging.

    Claim Your Free Sample of the Global Preclinical Imaging Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12393&type=smp

    What Are the Key Drivers of Growth in the preclinical imaging Market?

    The rise in persistent health conditions is anticipated to foster the expansion of the preclinical imaging market in the future. These persistent conditions, often known as chronic diseases, are long-term health issues that tend to last for a minimum of three months or even more. Such illnesses frequently require consistent medical supervision and can considerably affect an individual’s lifestyle. To detect these chronic diseases, tools like preclinical imaging are employed to display the skeletal structure and functionality of the lungs. It is also utilized to analyze chronic diseases, facilitating the visualization of disease progression and enhancing understanding of the illness. For illustration, the World Health Organization’s (WHO) 2022 Highlights in September 2022 stated that there were 41 million deaths worldwide, representing 74% of all deaths caused by noncommunicable or chronic diseases. This number includes 17.9 million deaths due to cardiovascular diseases, 9.3 million due to cancer, 4.1 million due to chronic respiratory diseases, and 2.0 million due to diabetes. Thus, the escalating incidence of chronic disease is propelling the growth of the preclinical imaging market.

    What Are the Notable Segments in the Preclinical Imaging Market?

    1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems

    2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents

    3) By End User: Hospital, Diagnostics Center, Other End-User

    Which Emerging Trends Are Altering the Preclinical Imaging Market?

    Gaining traction in the preclinical imaging market is the trend of product innovations. To maintain their standing in the market, leading companies in this sector are producing novel products. For instance, Fujifilm VisualSonics Inc., a Canadian biomedical company specializing in imaging system production, launched Vevo F2, an innovative product for preclinical imaging, in May 2022. The Vevo F2 is the first ultrasonic and photoacoustic imaging system to take preclinical imaging frequencies ranging from ultra-high at 71 MHz to low at 1 MHz. This state-of-the-art equipment touts HD image processing technology and a novel signal pathway, promising superior image clarity and stronger frame rates. It can be tailored to the specific accuracy requirements of imaging and has a variety of features such as a wide range of anatomical targets and high-resolution imaging. It is apt for a multitude of research applications.

    Order Now for Fast Delivery of Your Preclinical Imaging Market Report!

    https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

    Which Regions Are Most Influential in Expanding the Preclinical Imaging Market?

    North America was the largest region in the preclinical imaging market in 2023. The regions covered in the preclinical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Preclinical Imaging Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the preclinical imaging market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Preclinical Imaging Market Include

    1. Preclinical Imaging Market Executive Summary

    2. Preclinical Imaging Market Segments

    3. Preclinical Imaging Market Size And Template Market Growth Rate

    4. Key Preclinical Imaging Market Trends

    5. Major Preclinical Imaging Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Preclinical Imaging Market

    26. Top Preclinical Imaging Companies

    27. Preclinical Imaging Market Opportunities And Strategies

    28. Preclinical Imaging Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Pediatric Clinical Trials Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/pediatric-clinical-trials-global-market-report

    Virtual Clinical Trials Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

    Artificial Intelligence Services Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/artificial-intelligence-services-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Comprehensive Analysis On Size, Share, And Drivers Of The Preclinical Imaging Market

    Comprehensive Analysis On Size, Share, And Drivers Of The Preclinical Imaging Market

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    Product Innovations Drive Market Growth

    • Companies are investing in innovative products to maintain market position.
    • Example: Fujifilm VisualSonics Inc. introduced Vevo F2, an advanced preclinical imaging system.
    • Vevo F2 features customizable architecture, high-definition image processing, and versatile applications.

    Rigaku Corporation’s Strategic Acquisition Expands Market Reach

    • Rigaku Corporation’s acquisition of MILabs B.V. aims to strengthen its presence in life sciences.
    • MILabs B.V. specializes in manufacturing preclinical imaging systems for diverse research domains.
    • This acquisition enhances Rigaku Corporation’s research and development capabilities.

    View More On The Preclinical Imaging Market Report 2024 – https://www.thebusinessresearchcompany.com/report/preclinical-imaging-global-market-report

    Segmentation of the Preclinical Imaging Market

    1. By Modality
      • Optical Imaging Systems
      • Preclinical Nuclear Imaging Systems
      • Micro-magnetic Resonance Imaging Systems
      • Micro-Ultrasound Systems
      • Micro-computed Tomography Systems
      • Preclinical Photoacoustic Imaging Systems
      • Preclinical Magnetic Particle Imaging (MPI) Systems
    2. By Reagents
      • Preclinical Optical Imaging Reagents
      • Preclinical Nuclear Imaging Reagents
      • Preclinical MRI Contrast Agents
      • Preclinical Ultrasound Contrast Agents
      • Preclinical CT Contrast Agents
    3. By End User
      • Hospital
      • Diagnostics Center
      • Other End-User

    Rising Chronic Disease Burden Fuels Preclinical Imaging Market Growth

    Significance of Preclinical Imaging in Chronic Disease Management

    • Preclinical imaging facilitates the visualization of disease progression and treatment efficacy.
    • Chronic diseases, such as cardiovascular diseases, cancer, respiratory diseases, and diabetes, contribute significantly to global mortality rates.
    • Preclinical imaging tools aid in understanding chronic diseases, thereby driving market growth.

    Government Initiatives and Technological Advancements Propel Market Expansion

    • Government initiatives aimed at disease prevention and management bolster the demand for preclinical imaging.
    • Technological advancements enhance imaging accuracy and efficiency, fostering market growth.
    • Collaborations and partnerships among industry players stimulate innovation in preclinical imaging technologies.

    Forecasted Growth and Market Trends

    Promising Growth Prospects in the Forecast Period

    • The preclinical imaging market is projected to reach $4.42 billion by 2028, with a CAGR of 6.5%.
    • Factors driving growth include personalized medicine adoption and drug development outsourcing.

    Emerging Trends in the Preclinical Imaging Market

    • Green imaging technologies gain traction due to environmental concerns.
    • Increasing R&D activities propel innovation in preclinical imaging systems.
    • Real-time imaging capabilities offer new avenues for research and diagnosis.

    Conclusion

    The preclinical imaging market demonstrates robust growth prospects driven by factors such as rising chronic disease prevalence, technological advancements, and strategic collaborations. Innovations in imaging systems and reagents cater to diverse research needs, while market segmentation facilitates targeted strategies. As the market continues to evolve, stakeholders must adapt to emerging trends to capitalize on growth opportunities and contribute to advancements in healthcare and research.

    Request A Sample Of The Global Preclinical Imaging Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=12393&type=smp